Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704 (Q34600819)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704 (English)

1 reference

Europe PubMed Central

3 August 2017

chemoradiotherapy

0 references

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Adam C Berger

1

1 reference

Europe PubMed Central

3 August 2017

Miguel Garcia

2

1 reference

Europe PubMed Central

3 August 2017

John P Hoffman

3

1 reference

Europe PubMed Central

3 August 2017

William F Regine

4

1 reference

Europe PubMed Central

3 August 2017

Ross A Abrams

5

1 reference

Europe PubMed Central

3 August 2017

Howard Safran

6

1 reference

Europe PubMed Central

3 August 2017

Andre Konski

7

1 reference

Europe PubMed Central

3 August 2017

Alan B Benson

8

1 reference

Europe PubMed Central

3 August 2017

John MacDonald

9

1 reference

Europe PubMed Central

3 August 2017

Christopher G Willett

10

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

24 November 2008

1 reference

Europe PubMed Central

3 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

3 August 2017

26

1 reference

Europe PubMed Central

3 August 2017

36

1 reference

Europe PubMed Central

3 August 2017

5918-5922

1 reference

Europe PubMed Central

3 August 2017

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Role of tumour markers, cytogenetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Colorectal carcinoma antigens detected by hybridoma antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

7 July 2018

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

26 October 2018

A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

26 October 2018

Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645109

26 October 2018

Serum CA 19-9 in the postsurgical follow-up of patients with pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19029412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9

1 reference

https://pubmed.ncbi.nlm.nih.gov/19029412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19029412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19029412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.18.6288

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34600819&oldid=1617368188"